Hyperuricemia is a prevalent disease worldwide that is characterized by elevated urate
levels in the blood owing to purine metabolic disorders, which can result in gout and …

Uric acid disequilibrium is implicated in chronic hyperuricemia-related diseases. Long-term
monitoring and lowering of serum uric acid levels may be crucial for diagnosis and effective …

Hyperuricemia is an important metabolic disease of humans. Limited clinical drugs such as
allopurinol can alleviate hyperuricemia. Wild-type Escherichia coli Nissle 1917 (EcN) has …

Hyperuricemia is the second most prevalent metabolic disease to human health after
diabetes. Only a few clinical drugs are available, and most of them have serious side effects …

At present, the treatment of hyperuricemia is designed primarily to decrease the production
of uric acid using xanthine oxidase inhibitors; however, the therapeutic effect is not …

Hyperuricemia is a metabolic disease caused by disturbances in purine metabolism and
imbalances in the formation and excretion of uric acid. It is closely related to the gut …

Approximately 15% of US adults have circulating levels of uric acid above its solubility limit,
which is causally linked to the disease gout. In most mammals, uric acid elimination is …

Hyperuricemia (HUA) is the presence of excessive uric acid (UA) in blood, which leads to an
increased risk of chronic kidney disease and gout. Probiotics have the potential effect of …

Hyperuricemia has become the second most prevalent metabolic disease after diabetes, but
the limitations of urate-lowering treatment (ULT) drugs and patient nonadherence make ULT …

Hyperuricaemia (HUA) is a disorder of purine metabolism, which manifests itself as an
increase in uric acid production and a decrease in uric acid excretion, as well as a change in …